I agree that this site is using cookies. You can find further informations here.
X
Johne, Andreas
78  results:
Search for persons X
?
1

PP01.83 Treatment Sequencing in the VISION Study of Tepotin..:

Griesinger, Frank ; Garassino, Marina ; Felip, Enriqueta...
Journal of Thoracic Oncology.  19 (2024)  7 - p. e37-e38 , 2024
Link: https://doi.org/10.1016/..
 
?
2

PPD01.01 ctDNA Dynamics, Prognostic Markers and Resistance ..:

Le, Xiuning ; Garassino, Marina Chiara ; Ahn, Myung-Ju...
Journal of Thoracic Oncology.  19 (2024)  7 - p. e4 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Efficacy and safety of tepotinib in Asian patients with adv..:

Kato, Terufumi ; Yang, James Chih-Hsin ; Ahn, Myung-Ju...
British Journal of Cancer.  130 (2024)  10 - p. 1679-1686 , 2024
Link: https://doi.org/10.1038/..
 
?
4

Long‐term experience with tepotinib in Japanese patients wi..:

Morise, Masahiro ; Kato, Terufumi ; Matsumoto, Shingo...
Cancer Science.  115 (2024)  4 - p. 1296-1305 , 2024
Link: https://doi.org/10.1111/..
 
?
5

The Preclinical Pharmacology of Tepotinib—A Highly Selectiv..:

Albers, Joachim ; Friese-Hamim, Manja ; Clark, Anderson...
Molecular Cancer Therapeutics.  22 (2023)  7 - p. 833-843 , 2023
Link: https://doi.org/10.1158/..
 
?
6

Tepotinib in patients with non-small cell lung cancer with ..:

Le, Xiuning ; Paz-Ares, Luis G. ; Van Meerbeeck, Jan...
Cell Reports Medicine.  4 (2023)  11 - p. 101280 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Randomized Trial of Tepotinib Plus Gefitinib versus Chemoth..:

Liam, Chong Kin ; Ahmad, Azura Rozila ; Hsia, Te-Chun...
Clinical Cancer Research.  29 (2023)  10 - p. 1879-1886 , 2023
Link: https://doi.org/10.1158/..
 
?
8

Exposure–response analyses for the MET inhibitor tepotinib ..:

Xiong, Wenyuan ; Hietala, Sofia Friberg ; Nyberg, Joakim...
Cancer Chemotherapy and Pharmacology.  90 (2022)  1 - p. 53-69 , 2022
Link: https://doi.org/10.1007/..
 
?
9

Treatment effectiveness in a rare oncology indication: Less..:

Oksen, Dina ; Prince, Patricia ; Boutmy, Emmanuelle...
Clinical and Translational Science.  15 (2022)  8 - p. 1990-1998 , 2022
Link: https://doi.org/10.1111/..
 
?
10

Translational pharmacokinetic‐pharmacodynamic modeling of p..:

Xiong, Wenyuan ; Friese‐Hamim, Manja ; Johne, Andreas...
CPT: Pharmacometrics & Systems Pharmacology.  10 (2021)  5 - p. 428-440 , 2021
Link: https://doi.org/10.1002/..
 
?
11

Real-world insights into patients with advanced NSCLC and M..:

Bittoni, Marisa ; Yang, James Chih-Hsin ; Shih, Jin-Yuan...
Lung Cancer.  159 (2021)  - p. 96-106 , 2021
Link: https://doi.org/10.1016/..
 
?
12

Open-label, single-center, phase I trial to investigate the..:

Johne, Andreas ; Scheible, Holger ; Becker, Andreas...
Investigational New Drugs.  38 (2020)  5 - p. 1507-1519 , 2020
Link: https://doi.org/10.1007/..
 
?
13

Phase I trial of the MET inhibitor tepotinib in Japanese pa..:

Shitara, Kohei ; Yamazaki, Kentaro ; Tsushima, Takahiro...
Japanese Journal of Clinical Oncology.  50 (2020)  8 - p. 859-866 , 2020
Link: https://doi.org/10.1093/..
 
?
14

Safety, Tolerability, Pharmacokinetics, Target Occupancy, a..:

Becker, Andreas ; Martin, Emily C. ; Mitchell, David Y....
Clinical and Translational Science.  13 (2019)  2 - p. 325-336 , 2019
Link: https://doi.org/10.1111/..
 
?
15

A Novel PBPK Modeling Approach to Assess Cytochrome P450 Me..:

Lüpfert, Christian ; Dyroff, Martin ; von Richter, Oliver...
CPT: Pharmacometrics & Systems Pharmacology.  7 (2018)  12 - p. 829-837 , 2018
Link: https://doi.org/10.1002/..
 
1-15